2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$14.72+$0.66 (+4.72%)
Price as of Jun 23, 2026 6:20 PM EDT- $388.8MMarket Cap
- 92.08%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$14.72+$0.66 (+4.72%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.06 | ||
Change | +$0.69 (+5.16%) | ||
Open | $13.22 | ||
High | $14.12 | ||
Low | $12.92 | ||
Previous Close | $13.37 | ||
Volume | 401,620 | ||
30-Day Average Volume | 214,264 | ||
1-Week Change | 16.49% | ||
1-Month Change | 0.79% | ||
1-Year Change | 92.08% | ||
3-Year Change | -36.78% | ||
5-Year Change | -70.60% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $314.7M | ||
Market Cap | $388.8M | ||
Enterprise Value | $353.8M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | -$13.1M | ||
Free Cash Flow | -$7.2M | ||
EBIT | -$9.8M | ||
EBITDA | -$8.6M | ||
Net Working Capital | $132.0M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 3 | ||
P/E | -30 | ||
PEG | 4 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue